Vincristine sulfate
Marqibo, Oncovin (vincristine sulfate) is a small molecule pharmaceutical. Vincristine sulfate was first approved as Marqibo on 1982-01-01. It is used to treat hodgkin disease, leukemia, neuroblastoma, non-hodgkin lymphoma, and rhabdomyosarcoma amongst others in the USA. The pharmaceutical is active against tubulin beta chain.
| Trade Name | Marqibo, Oncovin |
|---|---|
| Common Name | Vincristine sulfate |
| Indication | hodgkin disease, leukemia, neuroblastoma, non-hodgkin lymphoma, rhabdomyosarcoma, wilms tumor |
| Drug Class | Vinca alkaloids |
